Fibroblasts represent a fundamental cell type within connective tissues, playing a crucial role in maintaining structural integrity and orchestrating wound healing and tissue repair. These elongated cells are responsible for synthesizing and secreting the extracellular matrix (ECM), a complex network of proteins and carbohydrates that provides structural support to various tissues and organs. Fibroblasts contribute to tissue homeostasis by regulating ECM composition and turnover, influencing mechanical properties and cellular behavior. In response to injury, fibroblasts become activated, adopting a myofibroblast phenotype that promotes contraction and ECM remodeling. This dynamic cellular activity is essential for tissue repair but can lead to fibrotic conditions when dysregulated, as observed in diseases like pulmonary fibrosis and liver cirrhosis. Fibroblasts also participate in immune responses, producing cytokines and chemokines that influence inflammation and immune cell recruitment. Moreover, their plasticity allows them to differentiate into diverse cell types, contributing to tissue regeneration. Understanding the multifaceted functions of fibroblasts is pivotal for unraveling the complexities of tissue development, repair, and pathological conditions, offering potential therapeutic avenues for diseases associated with aberrant fibroblast activity.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy